Bradley A. James Sells 2,694 Shares of Exponent, Inc. (NASDAQ:EXPO) Stock

Exponent, Inc. (NASDAQ:EXPOGet Free Report) VP Bradley A. James sold 2,694 shares of the company’s stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $79.52, for a total value of $214,226.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Exponent Stock Performance

EXPO opened at $76.20 on Friday. Exponent, Inc. has a one year low of $73.37 and a one year high of $115.75. The stock has a market capitalization of $3.87 billion, a PE ratio of 35.94 and a beta of 0.95. The business’s 50 day moving average price is $78.82 and its 200 day moving average price is $87.22.

Exponent (NASDAQ:EXPOGet Free Report) last released its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.04. Exponent had a return on equity of 27.27% and a net margin of 19.52%. The firm had revenue of $137.44 million for the quarter, compared to analysts’ expectations of $134.63 million. During the same period in the prior year, the firm posted $0.59 earnings per share. The firm’s quarterly revenue was up .2% on a year-over-year basis. As a group, equities research analysts forecast that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Exponent Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Shareholders of record on Friday, June 6th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.57%. The ex-dividend date of this dividend is Friday, June 6th. Exponent’s payout ratio is 58.54%.

Institutional Trading of Exponent

A number of institutional investors and hedge funds have recently added to or reduced their stakes in EXPO. Barclays PLC raised its position in Exponent by 219.0% in the third quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock valued at $11,127,000 after purchasing an additional 66,263 shares during the period. Trust Co. of Vermont purchased a new stake in Exponent in the fourth quarter valued at approximately $45,000. Mitchell & Pahl Private Wealth LLC raised its position in Exponent by 9.8% in the fourth quarter. Mitchell & Pahl Private Wealth LLC now owns 6,545 shares of the business services provider’s stock valued at $583,000 after purchasing an additional 584 shares during the period. Inspire Investing LLC raised its position in Exponent by 25.4% in the fourth quarter. Inspire Investing LLC now owns 4,495 shares of the business services provider’s stock valued at $401,000 after purchasing an additional 910 shares during the period. Finally, KBC Group NV raised its position in Exponent by 62.4% in the fourth quarter. KBC Group NV now owns 2,274 shares of the business services provider’s stock valued at $203,000 after purchasing an additional 874 shares during the period. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Exponent Company Profile

(Get Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Read More

Insider Buying and Selling by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.